How personalised medicine shapes breast cancer treatment? Why women with similar diagnoses receive different therapies based ...

Genmab scores a ‘hat trick’ with positive data for its experimental cancer drug, petosemtamab, Jefferies says.

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...

EXCLUSIVE: The U.K. drugmaker currently has five approved cancer medicines and a clinical-stage portfolio of about 15 assets.

The revision follows the Centre’s October 17 decision to cap trade margins on 137 non-scheduled cancer medicines.

Shanghai Junshi Biosciences has gained approval from the United States' Food and Drug Administration for a market launch of a ...

Genmab’s Petosemtamab, when combined with Merck’s blockbuster cancer therapy Keytruda, reduced the risk of death by 50% ...

For many people with breast cancer, the journey from their diagnosis to treatment is just the beginning of the road to ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new ...

By Dennis Thompson HealthDay ReporterMONDAY, Oct. 26, 2026 (HealthDay News) — Starting survivorship care for patients with ...

Family medicine physician Dr. Jessica Gray breaks down a promising new clinical trial for endometrial cancer treatment ...